Julie A. Lemm - Durham CT, US Stacey A. Voss - Wallingford CT, US Min Gao - Madison CT, US Susan E. Chaniewski - South Glastonbury CT, US Amy K. Sheaffer - Meriden CT, US Fiona McPhee - Wallingford CT, US
International Classification:
A61K 31/4725 A61K 31/7056 A61P 31/14 A61K 38/21
US Classification:
424 857, 514309, 424 854, 514 43
Abstract:
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.
Stacey A. Voss - Wallingford CT, US Min Gao - Madison CT, US Susan E. Chaniewski - South Glastonbury CT, US Amy K. Sheaffer - Meriden CT, US Fiona McPhee - Wallingford CT, US
International Classification:
A61K 38/06 A61K 45/06 A61K 31/4178
US Classification:
424 857, 514 219, 424 854, 514 43
Abstract:
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.